Carbazochrome sodium sulfonate is Yellow Solid
Carbazochrome is an antihemorrhagic for use in the treatment of hemorrhoids.
Carbazochrome Sodium Sulfonate Hydrate is a phosphatidylinositol hydrolysis inhibitor in endothelial cells.
Carbazochrome sodium sulfonate is a Phosphatidylinositol hydrolysis inhibitor in endothelial cells.
Carbazochrome inhibits the severe pulmonary dysfunction induced by the intravenous injection of radiographic contrast media. Carbazochrome (1-10 mg/kg, i.v.) attenuates pulmonary dysfunction induced by a radiographic contrast medium in rats[2].
| Animal Model: | Male Sprague-Dawley rats weighing 180-230 g[2] |
| Dosage: | 1, 5 and 10 mg/kg |
| Administration: | I.v.; injected 30, 60, or 90 min before Ioxaglate injection (4 g I/kg, i.v.). |
| Result: | Attenuated the Ioxaglate-increased vascular permeability at the dose of 1, 5 and 10 mg/kg in a dose-dependent manner, achieving statistical significance at 5 and 10 mg/kg. |
